The Use of Collagenase in the Treatment of Peyronie’s Disease
- 1 August 1985
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 134 (2), 280-283
- https://doi.org/10.1016/s0022-5347(17)47123-0
Abstract
Purified clostridial collagenase was administered intralesionally in 31 men with Peyronie's disease. Within 4 weeks of treatment 20 patients showed an objective improvement. Pain was eliminated in 13 of 14 patients with this complaint at presentation within the same 4-week period. The ability to have intercourse was restored in 3 of 4 patients with this problem. Except for a small corporeal rupture at the site of injection in 1 patient, no significant untoward effects were noted. During the mean 9.8-month followup 1 recurrence of bending was noted.Keywords
This publication has 14 references indexed in Scilit:
- Topical Beta-Aminopropionitrile in the Treatment of Peyronie’s DiseaseJournal of Urology, 1983
- Collagenase for Peyronie's disease experimental studiesUrological Research, 1982
- Pharmacologic Control of Surface Scarring in Human BeingsAnnals of Surgery, 1981
- Injection of Collagenase in the Treatment of Herniated Lumbar DiskPublished by American Medical Association (AMA) ,1981
- Ultrasound Imaging of Peyronie’s PlaquesJournal of Urology, 1981
- Inhibition of collagen cross-linking: A new approach to ocular scarringCurrent Eye Research, 1981
- Administration of beta-aminopropionitrile to human beings with urethral strictures: A preliminary reportThe American Journal of Surgery, 1978
- Surgical Treatment of Peyronie’s Disease: A New ApproachJournal of Urology, 1977
- Surgical Treatment of Peyronie’s Disease with a Dermal GraftJournal of Urology, 1974
- Peyronie's DiseaseAmerican Journal of Clinical Pathology, 1966